Theravance Biopharma, Inc. (TBPH)
17.01
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
17.00
-0.01
(-0.06%)
After-Hours: 20:00
Theravance Biopharma Price to Book Value : 3.047 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 3.047 |
| August 21, 2026 | 3.047 |
| August 20, 2026 | 3.036 |
| August 19, 2026 | 3.043 |
| August 18, 2026 | 3.036 |
| August 17, 2026 | 3.031 |
| August 14, 2026 | 3.040 |
| August 13, 2026 | 3.031 |
| August 12, 2026 | 3.031 |
| August 11, 2026 | 3.031 |
| August 10, 2026 | 3.029 |
| August 07, 2026 | 3.032 |
| August 06, 2026 | 3.031 |
| August 05, 2026 | 3.027 |
| August 04, 2026 | 3.024 |
| August 03, 2026 | 3.022 |
| July 31, 2026 | 3.020 |
| July 30, 2026 | 3.018 |
| July 29, 2026 | 3.018 |
| July 28, 2026 | 3.025 |
| July 27, 2026 | 3.020 |
| July 24, 2026 | 3.020 |
| July 23, 2026 | 3.020 |
| July 22, 2026 | 3.011 |
| July 21, 2026 | 3.016 |
| Date | Value |
|---|---|
| July 20, 2026 | 3.011 |
| July 17, 2026 | 3.032 |
| July 16, 2026 | 3.040 |
| July 15, 2026 | 3.032 |
| July 14, 2026 | 3.031 |
| July 13, 2026 | 3.027 |
| July 10, 2026 | 3.032 |
| July 09, 2026 | 3.041 |
| July 08, 2026 | 3.045 |
| July 07, 2026 | 3.047 |
| July 06, 2026 | 3.045 |
| July 02, 2026 | 3.032 |
| July 01, 2026 | 3.041 |
| June 30, 2026 | 3.045 |
| June 29, 2026 | 3.024 |
| June 26, 2026 | 3.125 |
| June 25, 2026 | 3.083 |
| June 24, 2026 | 3.062 |
| June 23, 2026 | 3.008 |
| June 22, 2026 | 2.936 |
| June 18, 2026 | 2.939 |
| June 17, 2026 | 2.962 |
| June 16, 2026 | 2.959 |
| June 15, 2026 | 2.893 |
| June 12, 2026 | 2.950 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Zymeworks, Inc. | 25.76 |
| Viatris, Inc. | 1.340 |
| Ocular Therapeutix, Inc. | 4.552 |
| ANI Pharmaceuticals, Inc. | 2.853 |
| Corcept Therapeutics, Inc. | 18.84 |
Price to Book Value Related Metrics
| PE Ratio | 16.85 |
| PS Ratio | 8.476 |
| PEG Ratio | 0.0509 |
| Price to Free Cash Flow | 16.45 |
| Price | 17.01 |
| Earnings Yield | 5.93% |
| Market Cap | 882.67M |
| PEGY Ratio | 0.0509 |
| Operating PE Ratio | 400.24 |
| Normalized PE Ratio | 14.22 |